D

Diasome Pharmaceuticals, Inc.

8 employees

Diasome Pharmaceuticals is a clinical-stage diabetes therapeutics company that designs and develops insulin-based therapies.

Basic info

biotechnology research

Biotechnology

Obesity

Life Science

Therapeutics

Hepatic Targeted Insulin Therapies

Oral Protein Delivery

Nanotechnology

Medical

Health Care

Type 1 and Type 2 Diabetes

2004

$30M

from 5 investors over 5 rounds

D

Diasome Pharmaceuticals, Inc. raised $30M on July 5, 2017

Investors: JDRF T1D Fund, Medicxi, - and McDonald Partners

D

Diasome Pharmaceuticals, Inc. raised $8.4M on April 15, 2008

Investors: Devon Park Bioventures